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Transcription-Coupled and Global Genome Repair
Differentially Influence UV-B-Induced Acute Skin Effects and
Systemic Immunosuppression1
Johan Garssen,2* Harry van Steeg,† Frank de Gruijl,‡ Jan de Boer,§
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Angelique Fluitman,* Geert Weeda,§ and Jan H. J. Hoeijmakers§
Exposure to UV-B radiation impairs immune responses in mammals by inhibiting especially Th1-mediated contact hypersensi-
tivity and delayed-type hypersensitivity. Immunomodulation is not restricted to the exposed skin, but is also observed at distant
sites, indicating the existence of mediating factors such as products from exposed skin cells or photoactivated factors present in
the superficial layers. DNA damage appears to play a key role, because enhanced nucleotide excision repair (NER) strongly
counteracts immunosuppression. To determine the effects of the type and genomic location of UV-induced DNA damage on
immunosuppression and acute skin reactions (edema and erythema) four congenic mouse strains carrying different defects in NER
were compared: CSB and XPC mice lacking transcription-coupled or global genome NER, respectively, as well as XPA and
TTD/XPD mice carrying complete or partial defects in both NER subpathways, respectively. The major conclusions are that 1)
transcription-coupled DNA repair is the dominant determinant in protection against acute skin effects; 2) systemic immunomodu-
lation is only affected when both NER subpathways are compromised; and 3) sunburn is not related to UV-B-induced
immunosuppression. The Journal of Immunology, 2000, 164: 6199–6205.
B esides the beneficial effects of UV exposure, such as vi-tamin D production, cosmetic tanning, and adaptation tosolar UV radiation, UV exposure can also have adverse
consequences on human health, notably sunburn, skin cancer, and
ocular damage. Over the last 2 decades it has become evident that
UV-B exposure (280–320 nm) also impairs specific and nonspe-
cific immune responses (1). Several studies have shown that UV-
B-induced immunomodulation plays at least a partial role in pho-
tocarcinogenesis (2). In addition, UV-B exposure has been
demonstrated to impair resistance to bacterial, viral, parasitic, and
fungal infections. Importantly, the effects of UV are not restricted
to skin-associated infections, but also to systemic (non-skin-asso-
ciated) infections (3–9). Because UV-B is not able to penetrate
much beyond the upper cell layers of the epidermis, UV-B-induced
immunosuppression is probably mediated by these exposed cells,
their products, or photoactivated factors present in the superficial
layers. UV irradiation can directly induce acute effects in the skin,
such as membrane damage resulting in activation of the transcrip-
tion factor NF-kB (10), activation of Src tyrosine kinases (11),
production of H2O2 (12), urocanic acid isomerization (13), and
neuropeptide release (14). Some of these are shown to be involved
in UV-B-induced immunomodulation, even at loci distant from the
UV-B-exposed skin (i.e., systemic immunosuppression). These in-
clude urocanic acid isomerization (13) and neuropeptide release (14).
In addition, DNA damage appears to play a crucial role in UV-
induced immunomodulation, locally as well as systemically. Ex-
posure to UV-B radiation, which induces cyclobutane pyrimidine
dimers (CPDs)3 as well as pyrimidine 6-4 pyrimidone photoprod-
ucts in DNA, suppresses cellular (i.e., T cell-dependent) immune
responses even when initiated at UV-unexposed sites. Cells with
DNA damage can migrate from the skin to other sites in the body.
The products released by exposed epidermal cells can be trans-
ported through the body by the circulation, which may contribute
to systemic immunosuppressive effects (15). Kripke and co-work-
ers demonstrated that DNA damage is at least partially involved in
local as well as systemic UV-induced immunomodulation. Direct
photoreactivation of CPDs (16, 17) and enhanced excision repair
of CPDs by T4N5 liposomes provided direct evidence that CPDs
induce the suppression of contact hypersensitivity (CHS) locally as
well as systemically. In addition, systemic suppression of delayed-
type hypersensitivity (DTH) to Candida albicans was also medi-
ated at least partially by CPDs (18, 19). Additional evidence for a
significant role of DNA damage in UV-B-induced immunosup-
pression was provided by Miyauchi-Hashimoto et al. (20), who
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demonstrated that in nucleotide excision repair (NER)-deficient
XPA mice local and systemic immunosuppression were increased.
Depending on the primary DNA lesions, one or more DNA re-
pair pathways become active. Examples are base excision repair,
recombinational repair, mismatch repair, and NER (21, 22). CPDs
and 6-4 photoproducts are important substrates for the NER path-
way. Both lesions are formed between adjacent pyrimidines, and
represent the major DNA damage induced by UV-B. NER also
removes a wide range of chemical adducts, and intrastrand DNA
cross-links in a complex “cut and paste” reaction mechanism in-
volving ;30 proteins (23). Two distinct subpathways can be dis-
cerned. Global genome NER eliminates lesions anywhere in the
genome in a lesion- and location-dependent manner. For lesions
such as CPDs, for which global genome NER is quite slow, a
second subpathway, designated transcription-coupled NER, has
evolved that preferentially eliminates damage that blocks ongoing
transcription. Both systems use common proteins as well as sub-
pathway-specific factors, and the processes operate in an indepen-
dent fashion.
In this study the sensitivity of four transgenic mouse models was
studied for UV-induced systemic immunomodulation (DTH and
CHS) and acute skin effects (i.e., edema). The NER-deficient
mouse mutants carried defects in the XPA, XPC, CSB, and XPD/
TTD genes (Table I). Conventional gene targeting of the mouse
XPA gene yielded a model for the UV-sensitive, cancer-prone pro-
totype DNA repair syndrome xeroderma pigmentosum (XP). XPA
deficiency induces a complete NER defect (24). XPC mice, on the
other hand, have a selective defect in global genome NER (25–27),
whereas CSB mice, mimicking the UV-sensitive neurodevelop-
mental condition Cockayne syndrome (CS), carry a specific im-
pairment of transcription-coupled repair. This mouse model was
obtained by mimicking a truncating CSB null allele found in a CS
group B patient (28). The fourth model mimics an XPD point
mutation of a trichothiodystrophy (TTD) patient that exhibits most
CS features as well as characteristic brittle hair and nails. The NER
defect includes both transcription-coupled as well as global ge-
nome NER, but is partial (29, 30).
Materials and Methods
NER-deficient mouse models
XPA, CSB, XPC, and TTD mice refer to NER-deficient mice homozygous
for the targeted allele in the respective genes (Table I) (24, 27–30).
Because in previous studies neither DNA repair defects nor an obvious
(UV-related) phenotype were found, heterozygous mice were not included
in the present experiments. Mixed 129-C57BL/6 or pure C57BL/6 litter-
mates of the homozygous knockout mice were used as control animals (the
background of all mutant strains used in this study). The genotype of each
mouse was determined by PCR. Mice were kept at an ambient temperature
of 25 6 1°C. The room was illuminated with yellow fluorescent tubes
(Philips TL40W/16; Philips, Eindhoven, The Netherlands) in a 12-h cycle
(switched on and off at, respectively, 0600 and 1800 h). These lamps do not
emit any measurable UV radiation. No daylight entered the animal facili-
ties. Animals were housed individually in Macrolon type I cages (Tecni-
plast, Gazzada, Italy) for the entire experiment. Standard mouse chow
(Hope Farms RMH-B, Woerden, The Netherlands) and tap water were
available ad libitum.
Formal permission for the animal experiments was granted by an inde-
pendent ethical committee of the National Institute of Public Health and the
Environment, as required by Dutch law.
Reagents
Picryl chloride (PCl; Chemotronix, Swannanoa, NC) was used as the con-
tact sensitizer. It was recrystallized three times from methanol/H2O before
use and protected from light during storage at 4°C.
Listeria monocytogenes bacteria
The strain of L. monocytogenes was isolated in 1973 from the cerebral
spinal fluid of an adult (human) male suffering from Listeria meningitis
(L242/73 type 4b). These bacteria lose their virulence after a few weeks of
culture. For this reason the culture was restimulated with an egg passage
before use in animal infection studies (31). Activated Listeria cells were
prepared by taking one colony scraped from a sheep blood agar plate, and
diluted in 8 ml of bovine broth. The suspension was incubated overnight at
37°C. After incubation bacteria were collected by centrifugation for 5 min
at 1200 3 g at 4°C. The pellet was resuspended in 8 ml of PBS and
vortexed. The solution contained ;5 3 108 Listeria/ml, as measured by
CFU on sheep blood agar plates. From this solution the desired infection
dilution was prepared. For inactivation the bacteria were heat-treated (10
min at 100°C). Thereafter, the sample was tested for inactivation using
overnight culture on sheep blood agar plates. Heat-killed L. monocytogenes
suspensions were used for ear challenge tests (DTH).
UV exposure
The animals were shaven (on the back) 1 day before UV exposure using an
electric clipper under light ether anesthesia. The animals were exposed to
broadband UV-B radiation from a filtered (Schott WG305 filter, Tiel, The
Netherlands) Hanovia Kromayer Lamp (model 10S, Slough, U.K.). This is
a hand-held lamp that allows short exposures to limited skin areas by
placing the circular port (;2 cm2) in close contact to the skin (32, 33). The
dose rate was 150 J/m2/s (280–400 nm), as measured by a Kipp E11
thermopile (Middleburg, The Netherlands).
For determination of acute effects the animals received only a single
dose, and for determination of immunomodulation the animals were ex-
posed to five consecutive UV doses (one exposure per day, last exposure
4 days before immunization or infection).
Quantification of acute UV effects
The mice were exposed on the shaven dorsal (back) skin in the early morn-
ing (between 0800–0900 h) and were critically diagnosed for edema and
erythema 24 h later by a biotechnician without knowledge of the treatment.
In other words all results were scored in a blinded fashion. Eight UV doses
were tested (from 1–32 s; i.e., 150-4800 J/m2), and at least three animals
were used per UV dose. The acute effects were categorized into four class-
es: 2, no detectable macroscopic effect; 1, slight, but detectable, edema/
erythema; 11, moderate edema/erythema; and 111, severe edema/ery-
thema and crust formation. Besides macroscopic evaluation of edema and
erythema, the increase in skin thickness was determined as a value of acute
UV effects in some experiments. In these cases the ears of mice were
exposed to the Kromayer UV source. Ear thickness was measured before
and 24 h after Kromayer exposure using an engineer’s micrometer (model
193–10, Mitutoyo, Veenendaal, The Netherlands) in a blinded fashion. The
lowest dose that was able to induce a significant ( p , 0.05 compared with
sham exposure) ear swelling response was the minimal erythema/edema
dose (MED) for that mouse strain.
CHS to PCl
The mice were skin-sensitized 4 days after the last day of (sham) irradia-
tion by topical application of 150 ml of 5% PCl in ethanol/acetone (3/1) to
the non-UV-irradiated shaved abdomen, chest, and four feet. Control mice
were sham-sensitized by topical application of 150 ml of ethanol/acetone
(3/1). Four days after sensitization both ears of the mice were challenged
by topical application of one drop (27-gauge needle) of 0.8% PCl in olive
oil. Before and at 24 h after challenge duplicate measurements of ear thick-
ness were made using an engineer’s micrometer in a blinded fashion. From
earlier studies it is known that the maximal CHS response occurred 24 h
after topical ear challenge even in UV-B-pre-exposed animals (33). In each
experiment, the increase in ear thickness in similarly challenged, nonsen-
sitized, control mice was measured at the same time and subtracted from
increments in ear thickness in sensitized test animals (net ear swelling).
Table I. NER mutant mouse strainsa
Mutant Strain
Global Genome Repair
(GGR)
Transcription Coupled
Repair (TCR)
XPA 2 2
CSB 1 2
XPC 2 1
TTD/XPD 1/2 1/2
a 2, Deficient; 1, normal; 1/2, intermediate.
6200 DNA REPAIR IN UV-B-INDUCED IMMUNOMODULATION
DTH to L. monocytogenes bacteria
The animals were infected s.c. (tail base) with ;2 3 104 activated
L. monocytogenes 4 days after the last day of (sham) irradiation. Six days
after the infection the animals in each group were injected s.c. in the ear
pinnea with 10 ml (107) of heat-killed Listeria particles under light ether
anesthesia. Before and at 24 h after Listeria ear challenge duplicate mea-
surements of ear thickness were made using an engineer’s micrometer as
outlined above (net ear swelling). In earlier studies it was demonstrated that
the maximal DTH response was found 24 h after s.c. ear challenge.
Statistics
Levels of significance were calculated using two-tailed Student’s t test; p ,
0.05 was taken as a significant difference between groups. For determina-
tion of the MED, at least three animals per dose and at least eight doses (1-,
2-, 4-, 6-, 8-, 10-, 16-, and 32-s Kromayer exposure) were tested. For
photoimmunology studies each group consisted of at least six mice, and
each experiment was repeated at least twice.
Results
CHS to PCl in XPA, CSB, TTD, and XPC and their wild-type
littermates
CHS in XPA, CSB, TTD, and XPC mice and their respective wild-
type littermates was measured 24 h after ear challenge with PCl in
olive oil. Significant CHS (ear swelling) responses ( p , 0.05) to
picrylchloride were observed in each strain of mouse compared
with the background swelling responses found in the nonsensitized
control animals from the same strain. Each bar in Fig. 1 represents
the net Ag-specific ear swelling response. The background ear
swelling in nonsensitized animals of each strain was always ,1 3
1023 cm.
In the mutant mice (XPA, XPC, TTD, CSB) the CHS responses
were not different from the CHS responses in the respective wild-
type littermates. Thus, the various NER defects did not affect the
normal T cell-dependent CHS response compared with CHS in the
repair-competent wild-type littermates.
DTH to L. monocytogenes in XPA, CSB, TTD, and XPC mice
and their wild-type littermates
DTH in the NER-deficient mutant mice and their respective wild-
type littermates was measured 24 h after ear challenge with heat-
killed Listeria bacteria. Fig. 2 shows the results. Each bar repre-
sents the net Ag-specific ear swelling response. The background
ear swelling in noninfected animals of each strain was always
,1 3 1023 cm. We detected significant DTH responses to heat-
killed Listeria particles in each strain of mouse compared with the
noninfected control animals from the same strain ( p , 0.05). In all
mutant mouse strains the DTH responses were not significantly
different from the DTH responses measured in control wild-type
littermates. However, a nonsignificant trend was observed in TTD
mice, which showed a lower DTH response to Listeria compared
with their normal littermates. In summary, the XPA, XPC, TTD,
and CSB mutant mice were not statistically significantly affected
with respect to the T cell-dependent immune response to L. mono-
cytogenes bacteria.
Acute skin effects induced by a single UV exposure
Acute macroscopic UV skin effects were studied ;24 h after a
single UV spot exposure. The MED for all wild-type littermates
was 1500 J/m2. The MED for the CSB and XPA mouse models was
,150 J/m2, consistent with the high UV sensitivity of the corre-
sponding human patients. The MED for the TTD mouse model was
1200 J/m2, thus slightly, but significantly, less than that in the
wild-type littermates. Remarkably, the MED for the XPC mouse
model was similar to that for the repair-proficient littermates, i.e.,
FIGURE 1. Net (Ag-specific) ear swelling 24 h after challenge of the
ear pinnea with one drop of 0.8% PCl in olive oil. The background swell-
ing, induced by PCl application to the ears in nonsensitized animals (,1 3
1023 cm), was subtracted from the swelling in PCl skin-sensitized animals.
All strains of mice demonstrated a significant (p , 0.05) CHS response
compared with the background response in nonsensitized controls of the
same strain. Each group contained at least six mice.
FIGURE 2. Net (Ag-specific) ear swelling 24 h after challenge of the
ears with heat-killed Listeria particles. The background swelling, induced
by the s.c. injection of heat-killed Listeria into the ears of noninfected
animals (,1 3 1023 cm), was subtracted from the swelling in Listeria-
infected animals. All strains of mice demonstrated a significant (p , 0.05)
DTH response compared with the background response in noninfected con-
trols of the same strain. Each group consisted of at least six mice.
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1500 J/m2. The detected effects are summarized in Table II for
each mouse strain.
UV-B-induced suppression of CHS
To compare suppressive effects distant from the site of UV expo-
sure on the shaven back, the control response in non-UV-exposed
animals was set at 100%. In each study the mutant mice were
compared with their wild-type littermates. The findings are de-
picted in Fig. 3. Each bar represents the percent CHS compared
with the control response in non-UV-exposed animals, which was
set at 100%. For CHS responses the minimal UV dose necessary
to induce a statistically significant suppression ( p , 0.05) was 6 s
for all wild-type control littermates (i.e., 900 J/m2; 280–400 nm).
The minimal dose necessary to suppress CHS in XPA mice was 1 s
or possibly even less (150 J/m2; 280–400 nm). In CSB and XPC
mice the minimal dose required to suppress CHS was 6 s, thus in
the same range as in their wild-type littermates. Finally, TTD mice
had to be exposed to 4 s (600 J/m2; 280–400 nm) to induce a
significant suppression of CHS, which is slightly but significantly
less than in their normal littermates.
UV-B-induced suppression of DTH to L. monocytogenes
In parallel to the influence on CHS we determined the suppressive
effects of distant UV exposure on DTH. To this aim the control
response in non-UV-exposed animals was set at 100%, and mutant
mice were compared with the control wild-type littermates. The
data are compiled in Fig. 4. Each bar represents the percent ear
swelling compared with the control response in non-UV-exposed
animals (set at 100%). For DTH responses to L. monocytogenes
the minimal UV dose that was necessary to significantly suppress
this immune response ( p , 0.05) was 4 s for the XPA wild-type
mice and 6 s for the CSB wild-type, TTD wild-type, and XPC
wild-type mice. The minimal UV dose necessary to induce a sta-
tistically significant suppression ( p , 0.05) was l s (150 J/m2) or
less for XPA mutants and 6 s (900 J/m2) for CSB, TTD, and
XPC mice.
Discussion
In our analysis CHS and DTH assays were used as tools to exam-
ine the role of DNA damage and repair in UV-induced immuno-
modulation. It is well known that this photoimmunomodulation
may have deleterious consequences for resistance to infections and
rejection of certain tumors, but may also be advantageous with
respect to certain autoimmune and/or hyperimmune diseases (1,
34). In our CHS studies PCl was used as the Ag. Previously, we
showed that low doses of UV-B could inhibit the CHS response to
PCl correlating with decreased levels of IFN-g and IL-12 (35, 36).
Both cytokines play crucial roles in the initiation and effector
phase of Th1-mediated immunity (35). We demonstrate here that
even when animals are exposed to suberythemal doses distant from
the sensitization locus, UV-B can easily inhibit CHS to PCl. In the
Table II. Acute skin effects induced by a single UV exposurea
UV dose (280–400 nm)
Mouse Strain
XPA,
1/1
XPA,
2/2
XPC,
1/1
XPC,
2/2
CSB,
1/1
CSB,
2/2
TTD,
1/1
TTD,
2/2
150 J/m2 2 1 2 2 2 1 2 2
300 J/m2 2 111 2 2 2 11 2 2
600 J/m2 2 111 2 2 2 111 2 2
900 J/m2 2 111 2 2 2 111 2 2
1200 J/m2 2 NT 2 2 2 111 2 1
1500 J/m2 1 NT 1 1 1 NT 1 11
2400 J/m2 111 NT 11 11 111 NT 111 111
4800 J/m2 111 NT 111 111 111 NT 111 111
a Acute skin effects 24 h after one single Kromayer spot exposure on the shaven dorsal skin in J/m2 (280–400 nm) (1/1, wild type; 2/2, mutant mice). NT, not tested
(ethically not allowed); 2, no macroscopic effects detectable; 1, slight but detectable edema reaction; 11, moderate edema reaction; 111, severe edema reaction and crust
formation. There was no difference detectable between the three animals per dose.
FIGURE 3. UV-B-induced systemic suppression of CHS to PCl in
NER-deficient mice and their control wild-type littermates. Each bar rep-
resents the net ear swelling. The net ear swelling in sensitized non-UV-
exposed animals was set at 100%. Each group (bar) contains at least six
mice. The p values reflect comparison with the UV-unexposed group (0 s
of Kromayer exposure).
6202 DNA REPAIR IN UV-B-INDUCED IMMUNOMODULATION
DTH studies L. monocytogenes was employed as an infective
agent. Suberythemal, distant UV exposure can inhibit specific cel-
lular immunity to L. monocytogenes. Lymphocyte proliferation as-
says as well as DTH responses to Listeria particles in a rat infec-
tion model were significantly inhibited after suberythemal UV
exposure (6). An increased Listeria load in the spleen and liver was
observed, which indicates that the cellular immune parameters
lymphocyte proliferation and DTH correlated well with impaired
resistance. In the current study the effect on DTH to Listeria de-
scribed in Wistar Unilever rats appeared to be reproducible in
mice. Mice were used because no mutant NER-deficient rat strains
were available.
The implications of defective NER in humans are apparent from
three autosomal, recessive syndromes: XP, CS, and the sunlight-
sensitive form of TTD (37). Seven complementation groups have
been described in NER (XP-A to XP-G), two in CS (CS-A and
CS-B), and three in TTD (XP-B, XP-D, and TTD-A). All XP-
related genes are involved in both global genome as well as tran-
scription-coupled repair with the exception of XPC, which acts in
global genome NER only (27). Hypersensitivity to sunlight is as-
sociated with skin cancer predisposition in the case of XP, but not
in patients with CS and TTD. Many studies indicate that the im-
mune system in XP patients is impaired, with lower DTH and
CHS, decreased CD4/CD8 ratios, impaired mitogen responsive-
ness and production of IFN-g, reduced NK cell activity, and de-
layed recovery of Langerhans cell depletion by UV (38–45).
These findings suggest that not only mutagenesis in skin cells but
also impaired immune surveillance or increased susceptibility to
UV-induced immunomodulation may contribute to the observed
skin cancer susceptibility in humans with XP. Immunological def-
icits have also been noted for CS and TTD.
CPDs and 6-4 photoproducts are the main DNA lesions induced
by UV. Both are substrates for the NER machinery. CPDs are very
efficiently repaired in the transcribed strand of active genes by
transcription-coupled repair, but repair of this lesion by global ge-
nome NER in the remainder of the genome is much slower and less
efficient. It is thought that especially CPDs play a critical role in
UV-induced immunomodulation (16, 18, 46). The less abundant
6-4 photoproducts are removed very rapidly and genome-wide by
global genome NER. When this NER mode is not operative, repair
in the transcribed sequences is taken over by the transcription-
coupled repair subpathway. Some important differences in NER
activity exist between rodents and man. In particular, CPDs (but
not 6-4 photoproducts) are hardly removed from nontranscribed
sequences in mice. However, this difference does not appear to
have severe consequences, because UV survival of wild-type
mouse and human fibroblasts is similar. Moreover, repair param-
eters in mouse fibroblasts from repair-deficient mice, such as un-
scheduled DNA synthesis (UDS), recovery of RNA synthesis after
UV exposure, and sensitivity to UV light, correlate very well with
those of human patients fibroblasts.
In this study four mouse strains carrying different NER defects
were investigated with respect to their sensitivity for UV-B re-
garding acute cutaneous and immunological effects (Table I, 2).
For instance, UDS is ,5% in XPA mice, 25% in TTD mice, 30%
in XPC mice, and .95% in CSB mice of the UDS found in wild-
type mice (30, 47) (see Table III). In addition, RNA synthesis
recovery is ,5% in XPA and CSB mice, ;20% in TTD mice, and
.95% in XPC mice compared with the 100% recovery found in
control wild-type littermates (30).
Acute skin effects due to a single UV-B exposure revealed that
XPA and CSB mice were at least 10-fold more sensitive than their
wild-type littermates. Miyauchi-Hashimoto et al. (20) reported that
XPA mice were hypersensitive to UV-B with respect to acute skin
effects such as edema, effects on Langerhans cells, and induction of
sunburn cells, in accordance with our study. Our findings indicate
that transcription-coupled repair, rather than global genome repair,
is responsible for the protection against acute skin effects. XPA
mice are affected in both NER subpathways, but CSB mutants are
only deficient in transcription-coupled repair. Berg et al. demon-
strated that acute UV effects, macroscopically characterized by
erythema and edema of the skin, are caused by lesions in actively
transcribed DNA and thus serve as a parameter for transcription-
coupled NER (48). A significant, but only mild, increase in sen-
sitivity for acute UV skin effects is observed in TTD mice. This
might be due to the fact that transcription-coupled repair is only
partially disturbed in TTD mice (30). XPC mice, on the other hand,
exhibit wild-type UV sensitivity, confirming the idea that erythema
and edema reactions induced by UV-B are primarily determined
by transcription-coupled repair and not significantly by global ge-
nome NER. For CSB-deficient mice UV sensitivity might be more
exaggerated compared with that in human CS, because global ge-
nome NER in the mouse does not eliminate CDPs from transcribed
sequences. In human CS this NER subpathway may still remove a
significant proportion of these transcription-blocking lesions. The
FIGURE 4. UV-B-induced systemic suppression of DTH to L. mono-
cytogenes in NER-deficient mice compared with wild-type littermates.
Each bar represents the net ear swelling. The net ear swelling in infected
non-UV-exposed animals was set at 100%. Each group contains at least six
mice. The p values reflect comparison with the UV-unexposed group (0 s
of Kromayer exposure).
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wild-type MED found for XPC-deficient mice fits very well with
the results of a study by Kondo et al. (49), who described XP-C
patients with normal MED. Extrapolating our observations from
mice to humans, it should be taken into account that the absence of
CPD removal by murine global genome NER makes a wild-type
mouse in this regard more like a human XPC mutant. As such, the
phototypical difference between wild-type and XPC mice is much
smaller compared with that in humans. However, XPC mice are
still extremely cancer-prone, exhibiting almost the same sensitivity
as XPA mice. The strong dependence of acute UV-B effects on a
functioning transcription-coupled repair process is in accordance
with the idea that blocked transcription constitutes a potent trigger
of p53 activation, resulting in apoptosis (50, 51).
Remarkably, strains with completely or partially active global
genome repair (CSB or TTD) are not significantly or are only mar-
ginally sensitive with respect to UV-induced systemic immuno-
modulation. However, XPC mice, with a total defect in this sub-
pathway, fail to display significant sensitivity in this regard,
whereas the total NER-deficient XPA animals were very sensitive.
This suggests that the trigger for inducing immunomodulation is
strongly reduced when NER is still partially active in either global
genome or transcription-coupled repair or partially in both. Alter-
natively, the activity of each of the NER pathways may have a
separate link with immune surveillance. The fact that XPC mice do
not show altered CHS and DTH, whereas it is a very cancer-prone
form of XP (see Table III), suggests that the onset of cancer is in
this case not dependent on compromising the immune system. On
the other hand, our finding of a near normal immune response in
CS and TTD can contribute to the low cancer susceptibility noted
with these conditions, particularly in man. Another important con-
clusion of our work is that acute UV effects, such as erythema or
edema, are not predictive for immunosuppression. This implies
that different molecular mechanisms underlie these phenomena.
Probably, the strong induction of apoptosis (sunburn) by UV is not
a major mechanism triggering the immune response.
A follow-up study might examine the role of TNF-a and/or
IL-10 in photoimmunosuppression, induced at least partially by
UV-induced DNA damage, in the four different NER-deficient
mouse strains. One of the most important issues for future research
are the roles of the different types of UV-induced DNA damage in
the induction of immunosuppression, although studies by Kripke et
al. indicate that CPDs in particular are crucial (16, 18). We found
a slight sensitivity of TTD mice for CHS. This suggests that 6-4
photoproducts are also involved, because the partial NER-deficient
TTD mice differ from CSB as well as XPC mice in the rate of
removal of this UV lesion in both the transcribed compartment and
the remainder of the genome. To gain more insight into the precise
roles of different types of UV damage, we are generating new
transgenic mouse models expressing CPD- and/or 6-4 photoprod-
uct-specific photoreactivating enzymes. These should be instru-
mental for assessing the relative contributions of both lesions in
the induction of photoimmunosuppression.
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